HK Stock Market Move | HAIXI PHARMA (02637) once rose over 7%, with a total market value exceeding HKD 11 billion.

HAIXI PHARMA (02637) once rose by over 7%, up 6.1% at the time of publication, trading at 140.9 Hong Kong dollars, with a trading volume of 159.45 million Hong Kong dollars, and a total market value exceeding 11 billion Hong Kong dollars. Public information shows that HAIXI PHARMA is a commercial-stage pharmaceutical company that integrates research and development, production, and sales capabilities, with a pipeline of innovative drugs in development. As of the disclosure date of the prospectus, HAIXI PHARMA has obtained approval for 15 generic drug products, covering various therapeutic areas including the digestive system, cardiovascular system, endocrine system, and nervous system. The company has also established a pipeline of four innovative drugs in development targeting cancer, ophthalmology, and respiratory diseases. In addition, its current average daily market capitalization has reached 9.94 billion Hong Kong dollars, exceeding the requirements for trading through the Hong Kong Stock Connect.